Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 26, 2021; 9(21): 5812-5821
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5812
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5812
Figure 3 Soluble programmed death-1 levels.
A: Levels were positively correlated with alanine transaminase (ALT) levels in all patients after 6 mo; B, C: Levels were positively correlated with ALT (B) and hepatitis B virus (HBV) DNA levels (C) in patients with hepatitis B surface antigen (HBsAg) loss after 6 mo; D, E: Levels were positively correlated with ALT (D) and HBV DNA levels (E) in patients with HBsAg loss after 12 mo; F, G: Levels were negatively correlated with HBsAg levels in all patients after 24 mo (F) and 48 mo (G). sPD-1: Soluble programmed death-1.
- Citation: Tan N, Luo H, Kang Q, Pan JL, Cheng R, Xi HL, Chen HY, Han YF, yang YP, Xu XY. Soluble programmed death-1 is predictive of hepatitis B surface antigen loss in chronic hepatitis B patients after antiviral treatment. World J Clin Cases 2021; 9(21): 5812-5821
- URL: https://www.wjgnet.com/2307-8960/full/v9/i21/5812.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i21.5812